Risk of opioid overdose during buprenorphine treatment for opioid use disorder in the fentanyl era. [PDF]
Chambers LC +9 more
europepmc +1 more source
State Prior Authorization Prohibitions and Buprenorphine Retention Among Privately Insured Patients.
Hu JC +6 more
europepmc +1 more source
Effectiveness and safety of therapies for patients with opioid use disorder: a systematic review and network meta-analysis. [PDF]
Kabra M +11 more
europepmc +1 more source
Identifying Optimal Thresholds for Early Opioid Use Frequency in Predicting Buprenorphine Outcomes. [PDF]
Votaw VR +3 more
europepmc +1 more source
Brief report: Meth, tranq, gas station heroin & other drugs complicating addiction treatment. [PDF]
Winstanley EL +5 more
europepmc +1 more source
Private Equity Acquisition and Buprenorphine Prescribing.
Holdaway T +5 more
europepmc +1 more source
MiBUP: A pilot randomized controlled trial of low-dose initiation of buprenorphine for opioid use disorder: Design and rationale. [PDF]
Hayes BT +8 more
europepmc +1 more source
The Buprenorphine Paradox: How Buprenorphine Triggers and Resolves Opioid Withdrawal. [PDF]
Haghdoost M +6 more
europepmc +1 more source
Comparative Evaluation of Efficacy of Transdermal Buprenorphine Patch versus Intraoperative Cocktail Injection for Post-operative Pain Relief in Total Hip Arthroplasty. [PDF]
Agrawal N +4 more
europepmc +1 more source
Pharmacokinetics and analgesic efficacy of fentanyl and buprenorphine in chicken embryos. [PDF]
Truhlar L +9 more
europepmc +1 more source

